戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 el, suggesting its utility for host directed adjunct therapy.
2 of this process by EACA may be beneficial as adjunct therapy.
3 modulation and hence can be beneficial as an adjunct therapy.
4 llus reuteri to be a promising candidate for adjunct therapy.
5 o the cholesterol managing compartment as an adjunct therapy.
6       Necroptosis inhibitors may be a viable adjunct therapy.
7 ction or NO scavengers might be an effective adjunct therapy.
8  The patient was treated with clopidogrel as adjunct therapy.
9 , supporting the development of age-specific adjunct therapies.
10 ppropriateness of empiric antimicrobials, or adjunct therapies.
11 osis in ICUs, including the use of novel and adjunct therapies.
12  lymphedema therapy (11 studies [47.8%]) and adjunct therapy (12 studies [52.2%]).
13 he potential to take advantage of zinc as an adjunct therapy against CoV-associated diseases.
14 -directed pharmacotherapies could provide an adjunct therapy against synaptic simplification caused b
15                                        Thus, adjunct therapies aiming to reduce OSA burden, such as s
16 s demonstrate phytocannabinoids to be a safe adjunct therapy alongside ART to mitigate chronic inflam
17                                              Adjunct therapies and ECMO criteria were the same in the
18 ve care unit, total length of hospital stay, adjunct therapies and procedures, and complications.
19 , development of new antituberculosis drugs, adjunct therapies and vaccines, coupled with visionary p
20             Nevertheless, safe and effective adjunct therapies are needed to optimize outcomes.
21 g-resistant tuberculosis (TB), host-directed adjunct therapies are urgently needed to improve treatme
22                                   MSCs as an adjunct therapy are safe and can now be explored further
23           There is a need for alternative or adjunct therapies, as resistance to currently used antiv
24 ug-eluting, covered stents), with or without adjunct therapy (atherectomy or intravascular lithotrips
25 s provide an important proof-of-concept that adjunct therapies can synergize with anti-CD40L Abs to t
26                                              Adjunct therapy consisting of antiarrhythmic drugs or ra
27 t that plcR may represent a target for which adjunct therapies could be designed for the prevention o
28 chronization therapy (CRT) is an established adjunct therapy currently undergoing several interesting
29           This ozone treatment was used with adjunct therapy delivered by the system in vitro.
30 f HIV to antiviral compounds, exploration of adjunct therapies directed at host responses in combinat
31 PI5P liposomes as a promising alternative or adjunct therapy, especially for those who cannot access
32 e systemic therapy, but several locoregional adjunct therapies exist.
33  in randomized controlled clinical trials as adjunct therapies for shortening the duration of tubercu
34 argets, thereby aiding in the development of adjunct therapies for the management of HAND, which are
35 lopment of epigenetic drugs, or epidrugs, as adjunct therapies for treating CNS disorders, including
36               Tamoxifen is widely used as an adjunct therapy for breast cancer.
37 genic effects, identifying it as a promising adjunct therapy for cancer and other serious muscle wast
38              RB-PDAT can be considered as an adjunct therapy for cases of severe, progressive infecti
39 ines recommend zinc supplementation as a key adjunct therapy for childhood diarrhea in developing cou
40 est that IL-12 gene therapy could be used as adjunct therapy for coccidioidomycosis.
41    Therefore, exercise may represent a novel adjunct therapy for FEP.
42 APD hydrogels for clinical translation as an adjunct therapy for GBM treatment.
43 ion has been gaining relevance as a possible adjunct therapy for HAND.
44     Thus, our vaccine represents a promising adjunct therapy for heroin addiction, providing continuo
45  of GABAA-Rs and/or GABAB-Rs may be a useful adjunct therapy for human islet transplantation.
46 ne administration in AIDS may play a role as adjunct therapy for infections.
47                       RB-PDAT is a potential adjunct therapy for infectious keratitis that may reduce
48 odrug (SAPD) hydrogel that can be used as an adjunct therapy for local treatment of GBM following max
49 rmones, an approach that would be a valuable adjunct therapy for patients receiving inhibitors of bon
50        Intracoronary gamma-radiation used as adjunct therapy for patients with in-stent restenosis si
51 a-Radiation with a 90-yttrium source used as adjunct therapy for patients with ISR results in a lower
52   These results support the use of IFN as an adjunct therapy for patients with PML.
53 er investigation of this compound as a novel adjunct therapy for reperfusion injury.
54 39 enzymatic activity may find utility as an adjunct therapy for secondary hepatic malignancies.
55 promotes social behavior, and is a potential adjunct therapy for social deficits in schizophrenia and
56 d interest in using vitamin D3 (VitD3) as an adjunct therapy for TB because numerous in vitro studies
57 geting HIF-2alpha/PAI-1 will be an effective adjunct therapy for the treatment of PDR patients.
58 gs suggest that levodopa be considered as an adjunct therapy for the treatment of spastic quadriplegi
59 e transfusion has been used as an aggressive adjunct therapy for this condition.
60       Thus, PGG use may be recommended as an adjunct therapy for TNBC to increase chemotherapy effect
61 agonists to hPXR may prove to be a promising adjunct therapy for tuberculosis.
62  parasite densities >10% and those requiring adjunct therapy had significantly higher parasite cleara
63 ptor tyrosine kinase inhibitors, are used as adjunct therapies in a number of cancer treatments.
64   Exercise holds significant potential as an adjunct therapy in cancer, extending beyond quality-of-l
65 ysical exercise remains a potentially useful adjunct therapy in CD.
66 mechanism of action, it may be beneficial as adjunct therapy in CHF patients.
67  can serve as possible viable candidates for adjunct therapy in colon cancer treatment.
68 inhibition might have clinical utility as an adjunct therapy in management of liver cancer.
69 ay be used as a novel, safe, and inexpensive adjunct therapy in multiorgan donation.
70 -36) amide is a safe and efficacious form of adjunct therapy in patients with hyperglycemia in the su
71 ulation, is showing increasing promise as an adjunct therapy in rehabilitation following stroke.
72 ng sepsis and suggest that MDC may aid in an adjunct therapy in sepsis.
73 ion or neutralization of MIF may serve as an adjunct therapy in sepsis.
74 hat early treatment with IL-10 may be useful adjunct therapy in some types of viral encephalitis.
75 al disease over time and can be an important adjunct therapy in the comprehensive treatment of period
76          Vitamin D could be beneficial as an adjunct therapy in the treatment of allergic asthma.
77 Clinically, consideration of antioxidants as adjunct therapy in type 2 diabetes is warranted because
78                                              Adjunct therapy interventions included advanced pneumati
79 hase 2 and 3 trials are underway, and use of adjunct therapies is being explored for drug-sensitive a
80                                        As an adjunct therapy, metformin enhances the efficacy of conv
81                                 When used as adjunct therapy, mibefradil did not affect the usual out
82  implications for the potential of VPA as an adjunct therapy not only for cognitively impaired patien
83 identifying a vasoprotecting strategy by the adjunct therapy of 5-FU with Resveratrol.
84 rtant targets relevant to chemoprevention or adjunct therapy of ChC.
85 ynamic therapy looks extremely promising for adjunct therapy of intrahepatic mass lesions.
86 nse, and represent specific interfaces where adjunct therapy or biased ligands may improve beta-agoni
87 o enable simple and effective application of adjunct therapy, ozone delivery and topical antibiotics
88 pportive care and pain management-analgesia, adjunct therapies, radiotherapy, surgery, systemic antic
89   This study advocates a novel host directed adjunct therapy regimen for TB with a clinically approve
90 , ganciclovir and foscarnet combination, and adjunct therapy such as CMV-specific cytotoxic T-lymphoc
91 n protocols and advancing the development of adjunct therapies, such as advanced therapy medicinal pr
92                                              Adjunct therapies that target spore germination or downs
93           Ideally, neuroscience would inform adjunct therapies that target the neurotransmitter syste
94     The role of nutritional interventions as adjunct therapies to ART merits further investigation.
95 f new, more effective tuberculosis drugs and adjunct therapies to improve treatment outcomes are urge
96 provements in recanalisation with the use of adjunct therapies to intravenous thrombolysis.
97 tive agents can and should be re-examined as adjunct therapies to recanalization.
98 ophylactic antibiotic could be considered as adjunct therapy to antiseizure medication, as it might r
99  mechanism whereby rapamycin may serve as an adjunct therapy to attenuate progression of the disease.
100             We conclude that PBM is a simple adjunct therapy to attenuate the development of diabetic
101              Thus, ADAM II could serve as an adjunct therapy to AZT and NNRTIs that select for L100I
102 ysK2 serve as unique, attractive targets for adjunct therapy to combat mycobacterial infection.
103 r molecular means could serve as a potential adjunct therapy to combat oxidative stress and inhibit t
104 c antagonism of thrombin may be useful as an adjunct therapy to complement inhibition for xenograft r
105 ythmic agents are increasingly being used as adjunct therapy to decrease the frequency of ICD dischar
106 uld be further investigated as an option for adjunct therapy to existing desensitization for patients
107 his heterologous axis may hold promise as an adjunct therapy to frontline tuberculosis drugs.
108 ants can offer an achievable and inexpensive adjunct therapy to help inhibit the development of retin
109 cid supplementation represents an achievable adjunct therapy to help prevent vision loss in diabetic
110 icacy and safety of the SGLT-2 inhibitors as adjunct therapy to insulin in T1DM, clinical trials inde
111 ates that SGLT-2 inhibitors are effective as adjunct therapy to insulin in T1DM, heralding improved g
112 ge 1 of the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic C
113 g OUtMATCH (Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic P
114  a view to aiding the design of an effective adjunct therapy to overcome efflux-mediated resistance i
115 candidate therapeutic target and a promising adjunct therapy to PD-1 blockade for the treatment of HI
116 vation of the periphery, and may be a useful adjunct therapy to peripheral nerve repair.
117  Hence, inositol represents a possible novel adjunct therapy to prevent human NTDs.
118     SGLT2 inhibitors may be considered as an adjunct therapy to reduce anemia incidence in patients w
119 potentially may be used as an alternative or adjunct therapy to standard agents used to treat wound i
120  raising the possibility of using CPAi as an adjunct therapy to suppress certain cancers.
121 ient approach may yet prove beneficial as an adjunct therapy to traditional approaches.
122 olysis emerged as a potential replacement or adjunct therapy to vitrectomy.
123  system and that this can be exploited as an adjunct therapy together with standard drug-based approa
124                                     Finally, adjunct therapies under investigation will be reviewed.
125   Stand-alone atherectomy was attempted, and adjunct therapy was used for residual stenosis.
126 elopment of neovascular sequelae or need for adjunct therapies were recorded for consecutive visits a
127  surgical debridement alone or combined with adjunct therapies) were compared.
128          High-quality evidence was found for adjunct therapy with kinesio taping.
129 ld be a promising lead for treating VL as an adjunct therapy with miltefosine.
130                                              Adjunct therapy with tolerogenic nanoparticles represent
131 at delivers and utilizes gaseous ozone as an adjunct therapy with topical antibiotics through a novel
132 n and an adenosine diphosphate-antagonist an adjunct therapy with vasodilators and gpIIb/IIIa inhibit

 
Page Top